MARKET INSIGHT


this distinction particularly important when considering the use of xylitol in confectionery and other food products? Measuring xylitol in the blood isn’t the same as measuring how much xylitol someone eats. Xylitol is also naturally produced by the body, so higher circulating levels don’t necessarily mean that someone ate more xylitol-containing foods. This distinction was particularly clear


in the researchers’ 2024 study. In a small human experiment, xylitol levels rose sharply after participants drank a xylitol-sweetened drink. However, xylitol has a short half-life in the blood of around 13 minutes and levels returned close to baseline within 4–6 hours. The blood samples used in the observational part of that study were collected after an overnight fast. It’s therefore likely that the cardiovascular risks observed in the cohorts were associated with endogenous (internally produced) xylitol, rather than dietary intake.


How significant are the study’s observational design and the fact that the findings have not yet been published as a full peer-reviewed paper when assessing their implications for the industry? Both are important when assessing the strength of the evidence. An observational study can identify an association but cannot establish that one factor caused


another. Researchers can adjust statistically for known cardiovascular risk factors, as was done here, but other measured or unmeasured factors may still contribute to the association. The findings have also so far been


presented at a congress as a conference abstract. It’s common for researchers to present findings at scientific conferences before the full paper is published, as this allows them to share new research and discuss it with other experts in the field. However, a conference abstract provides much less detail about the study than a full scientific paper.


The research identifies an association rather than proving causation. What are the key factors that could potentially explain this association? There are several possible explanations. It could indeed be true that higher circulating xylitol itself could contribute to cardiovascular risk. Another is that higher circulating xylitol is a marker of underlying metabolic processes or health conditions that are themselves associated with cardiovascular risk. For example, differences in glucose metabolism, kidney function, cardiometabolic health or other metabolic pathways could potentially influence both circulating xylitol levels and cardiovascular


risk. Lifestyle factors such as diet, physical activity or smoking could also play a role if they weren’t fully accounted for. The researchers adjusted their analyses


for traditional cardiovascular risk factors, which reduces the likelihood that these factors explain the association, but it cannot completely rule out residual confounding which is where measured factors are not fully accounted for, or other relevant factors were not measured. Since only the conference abstract is currently available, we don’t yet have enough information about exactly which factors were included in the analyses and how they were measured.


How should the reported cardiovascular risk findings be viewed alongside the existing evidence on xylitol, including its established applications in sugar-free confectionery and chewing gum? The 2026 findings should be viewed as part of an evolving evidence base. The 2024 research first reported an association between circulating xylitol and cardiovascular events in people undergoing cardiac evaluation, alongside experimental findings on blood clotting. The new 2026 research is important because it finds an association in two much larger general- population cohorts, rather than only in a higher-risk clinical population.


OCTOBER 2026 • KENNEDY’S CONFECTION • 41


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60